ArticleThoracic cancer2023

Using the neutrophil-to-lymphocyte ratio to predict the outcome of individuals with nonsquamous non-small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed.

Hisao Imai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.